Considerations for Treatment of PSMA-Staged High-Risk Patients in Community Practice
This activity discusses the use of PSMA PET for staging in high-risk prostate cancer. This includes when to order a PSMA PET, how to interpret it, common pitfalls and controversies of the scans.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Salivary and Sinonasal Tumors: Multi-Disciplinary Individualization of Patient Care
Sinonasal and salivary malignancies are less common head and neck tumors but are still frequently seen by radiation oncologists and pose complex clinical decision making challenges due to the proximity to the facial nerve, optic structures, brain, and oral cavity.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ASTRO/ESTRO Joint Session – Overview of ASTRO/ESTRO Oligometastatic NSCLC Clinical Practice Guidelines: Case-Based Interactive Discussion
One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Which Patients Benefit from Radiation Therapy in Diffuse Large B-Cell Lymphoma in 2023? Recent Evidence and Future Developments
The role of RT in DLBCL is changing. Recent randomized studies have challenged the role of RT in the primary treatment of DLBCL but they included selected patient populations, making application of results in routine clinical practice difficult.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
ASTRO/ILROG Joint Session - When Every Centigray Counts: Expert Panelists on Approaching and Optimizing the Most Challenging Lymphoma Plans
Ongoing advances in technology have allowed for the shrinkage of target volumes and lowering of doses in the treatment of lymphomas with radiation.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Challenging Cases in Patient Safety: The Nation’s Experience Navigating New Technologies as Told to RO-ILS
When implementing newer technologies practices often rely on vendor training, an evaluation of published literature, and collaboration with others experienced in the technology. Incident learning has a critical role in radiation therapy and may be most important in new and emerging technologies.
Category
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiobiology-guided Innovations in the Integration of Radiation & Immunotherapies
Radiation and immunotherapies are commonly utilized sequentially or concurrently for the treatment of cancer patients, yet we are still developing our understanding of the optimal approaches for safely and effectively integrating these treatments.
Category
  • Immunotherapy
  • Radiobiology
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Pushing the Boundaries: Re-Irradiation for Pediatric Brain Tumors
Over the last 10 years, new studies have emerged demonstrating efficacy and safety of re-irradiation for children with recurrent brain tumors.
Category
  • Central Nervous System
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Cancer Stem Cells (CSC) and Radiation Response: Current Views and Future Perspectives in Radiation Oncology
Given the rate of scientific advances over the past 20 years, it is difficult for practicing radiation oncologists to stay abreast of the latest drugs, their targets and mechanisms of action.
Category
  • General RO
  • Radiobiology
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Combined Modality Therapy for Lymph Node Positive Prostate Cancer
Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages